within Pharmacolibrary.Drugs.ATC.M;

model M02AA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 4.1666666666666667e-07,
    adminDuration  = 600,
    adminMass      = 150 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00016,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M02AA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Oxyphenbutazone is a nonsteroidal anti-inflammatory drug (NSAID) in the pyrazolidinedione class, formerly used for the treatment of pain and inflammation in conditions like arthritis. Due to significant safety concerns, including serious adverse hematologic reactions, it is no longer approved or widely used in most countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults based on available references for structurally similar NSAIDs and limited legacy reports. No published detailed compartmental PK models found for oxyphenbutazone.</p><h4>References</h4><ol><li><p>Aarbakke, J (1978). Clinical pharmacokinetics of phenylbutazone. <i>Clinical pharmacokinetics</i> 3(5) 369–380. DOI:<a href=&quot;https://doi.org/10.2165/00003088-197803050-00003&quot;>10.2165/00003088-197803050-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/359213/&quot;>https://pubmed.ncbi.nlm.nih.gov/359213</a></p></li><li><p>Jaraiz, V, et al., &amp; San Andres, MI (1999). Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses. <i>Journal of veterinary pharmacology and therapeutics</i> 22(4) 247–254. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2885.1999.00219.x&quot;>10.1046/j.1365-2885.1999.00219.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10499236/&quot;>https://pubmed.ncbi.nlm.nih.gov/10499236</a></p></li><li><p>Verbeeck, RK (1990). Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs. <i>Clinical pharmacokinetics</i> 19(1) 44–66. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199019010-00004&quot;>10.2165/00003088-199019010-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2199127/&quot;>https://pubmed.ncbi.nlm.nih.gov/2199127</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M02AA04;
